PerloffM.: Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non cross-resistant regimen: a CALGB study.J Clin Oncol14: 1589, 1995.
2.
BonadonnaG.: Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes (ten-years results).JAMA273: 542, 1995.
3.
BerghJ., WiklundT., EriksteinB.: Tailored fluorouracil, epirubicin and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.Lancet356: 1384–1391, 2000.
